SHORT MINI-FUTURE - BIOGEN IDEC | Real-time Boerse Frankfurt Warrants 15:53:29 28/06/2024 BST | ||
| 14.77 EUR | -4.28% |
|
| Current month | -0.45% | ||
| 1 month | -3.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 14.77 | -4.28% |
| 27/06/24 | 15.43 | -3.38% |
| 26/06/24 | 15.97 | +1.20% |
| 25/06/24 | 15.78 | +1.94% |
| 24/06/24 | 15.48 | -2.15% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 03:53 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8VD4 |
| ISIN | DE000VQ8VD41 |
| Date issued | 22/06/2021 |
| Strike | 392.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.57 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.67 € |
|---|---|
| Lowest since issue | 1.52 € |
| Spread | 0.03 € |
| Spread % | 0.20% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.7
USD
Average target price
283.2
USD
Spread / Average Target
+23.80%
- Stock Market
- Certificates
- Certificat
